Skip to main content

Table 3 Psychiatric medications being taken at hospital discharge

From: No difference in COVID-19 treatment outcomes among current methamphetamine, cannabis and alcohol users

 

Group

  

METH (N = 32)

n (%)

Cannabis (N = 46)

n (%)

Alcohol (N = 44)

n (%)

Total (N = 122)

n (%)

P-value

Any Psychiatric Medications

17 (53.1%)

30 (65.2%)

26 (59.1%)

73 (59.8%)

0.55871

Antidepressants

9 (28.1%)

21 (45.7%)

18 (40.9%)

48 (39.3%)

0.28651

Antipsychotics

6 (18.8%)

8 (17.4%)

10 (22.7%)

24 (19.7%)

0.80711

Mood Stabilizers

3 (9.4%)

1 (2.2%)

1 (2.3%)

5 (4.1%)

0.21511

Anxiolytics

4 (12.5%)

8 (17.4%)

11 (25.0%)

23 (18.9%)

0.36881

Attention deficit disorder medications

2 (6.3%)

1 (2.2%)

3 (6.8%)

6 (4.9%)

0.54831

Sleep Medications

4 (12.5%)

7 (15.2%)

7 (15.9%)

18 (14.8%)

0.91221

Benzodiazepines

3 (9.4%)

4 (8.7%)

3 (6.8%)

10 (8.2%)

0.91151

PTSD (Post-traumatic stress disorder) medications

0 (0.0%)

1 (2.2%)

2 (4.5%)

3 (2.5%)

0.44471

Others (anticonvulsants or Parkinson disease or pain medications used off label)

2 (6.3%)

1 (2.2%)

3 (6.8%)

6 (4.9%)

0.54831

  1. 1Chi-Square p-value